Practitioner-level determinants of inappropriate prostate-specific antigen screening

Archives of Internal Medicine

Volumn 167, Issue 13, 2007, Pages 1367-1372

  Kerfoot, B Price ^a,b   Holmberg, Erika F ^a   Lawler, Elizabeth V ^a,b,c   Krupat, Edward ^b   Conlin, Paul R ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DATA BASE; FEMALE; HEALTH CARE PERSONNEL; HOSPITAL; HUMAN; IMMUNOASSAY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; NORMAL HUMAN; NURSE; PHYSICIAN; PHYSICIAN ASSISTANT; POISSON DISTRIBUTION; PRIORITY JOURNAL; PROSTATE CANCER; SCREENING TEST; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS; UROLOGY; VETERAN;

ADULT; FEMALE; GUIDELINE ADHERENCE; HEALTH PERSONNEL; HOSPITALS, VETERANS; HUMANS; MALE; MASS SCREENING; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; NEW ENGLAND; NURSE PRACTITIONERS; PHYSICIAN ASSISTANTS; PRACTICE GUIDELINES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; UROLOGY;

EID: 34447331294     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.13.1367     Document Type: Article

References (27)

1. National Comprehensive Cancer Network (NCCN). Prostate Cancer Early Detection (Version 1.2005). http://www.nccn.org. Accessed May 26, 2005.
2. US Preventive Services Task Force. Screening for prostate cancer: recommendations and rationale. Am Fam Physician. 2003;67(4):787-792.
3. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2005. CA Cancer J Clin. 2005;55(1):31-44.
4. American Urological Association (AUA). Prostate-specific antigen (PSA) best practice policy. Oncology (Williston Park). 2000;14(2):267-272, 277-278, 280.
5. Hoffman RM. Viewpoint: limiting prostate cancer screening. Ann Intern Med. 2006;144(6):438-440.
6. Tannock IF. Eradication of a disease: how we cured symptomless prostate cancer. Lancet. 2002;359(9314):1341-1342.
7. DiSantostefano RL, Lavelle JP. The economic impact of prostate cancer screening and treatment. N C Med J. 2006;67(2):158-160.
8. Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296(19):2336-2342.
9. Jerant AF, Franks P, Jackson JE, Doescher MP. Age-related disparities in cancer screening: analysis of 2001 Behavioral Risk Factor Surveillance System data. Ann Fam Med. 2004;2(5):481-487.
10. Scales CD Jr, Curtis LH, Norris RD, Schulman KA, Albala DM, Moul JW. Prostate specific antigen testing in men older than 75 years in the United States. J Urol. 2006;176(2):511-514.
11. Lu-Yao G, Stukel TA, Yao SL. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst. 2003;95(23):1792-1797.
12. Hall JA, Palmer RH, Orav EJ, Hargraves JL, Wright EA, Louis TA. Performance quality, gender, and professional role: a study of physicians and nonphysicians in 16 ambulatory care practices. Med Care. 1990;28(6):489-501.
13. Boulis AK, Long JA. Gender differences in the practice of adult primary care physicians. J Womens Health (Larchmt). 2004;13(6):703-712.
14. Choudhry NK, Fletcher RH, Soumerai SB. Systematic review: the relationship between clinical experience and quality of health care. Ann Intern Med. 2005;142(4):260-273.
15. Arias E. United States life tables, 2003. Natl Vital Stat Rep. 2006;54(14):1-40.
16. Fisher ES, Wennberg JE, Stukel TA, Sharp SM. Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven. N Engl J Med. 1994;331(15):989-995.
17. Guadagnoli E, Hauptman PJ, Ayanian JZ, Pashos CL, McNeil BJ, Cleary PD. Variation in the use of cardiac procedures after acute myocardial infarction. N Engl J Med. 1995;333(9):573-578.
18. Ashton CM, Petersen NJ, Souchek J, et al. Geographic variations in utilization rates in Veterans Affairs hospitals and clinics. N Engl J Med. 1999;340(1):32-39.
19. Sirovich BE, Gottlieb DJ, Welch HG, Fisher ES. Variation in the tendency of primary care physicians to intervene. Arch Intern Med. 2005;165(19):2252-2256.
20. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians follow clinical practice guidelines? a framework for improvement. JAMA. 1999;282(15):1458-1465.
21. González HM, West B, Underwood W III. PSA testing in office-based clinics: are we testing as much as we think? J Am Coll Surg. 2005;201(6):906-912.
22. Bell DS, Hays RD, Hoffman JR, Day FC, Higa JK, Wilkes MS. A test of knowledge about prostate cancer screening: online pilot evaluation among Southern California physicians. J Gen Intern Med. 2006;21(4):310-314.
23. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med. 2004;350(22):2239-2246.
24. Kane RA, Littrup PJ, Babaian R, et al. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer: findings of the American Cancer Society National Prostate Cancer Detection Project. Cancer. 1992;69(5):1201-1207.
25. Volk RJ, Spann SJ, Cass AR, Hawley ST. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med. 2003;1(1):22-28.
26. Skelton NK, Skelton WP III. Changing physician PSA ordering patterns through education. Arch Intern Med. 1994;154(7):819-820.
27. Bates DW, Kuperman GJ, Rittenberg E, et al. A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory tests. Am J Med. 1999;106(2):144-150.